BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25518581)

  • 21. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of renal anemia in hemodialysis patients in General Hospital Bjelovar from 2007 to 2010].
    Lovcić V; Vujić J; Basić-Jukić N; Kurtović I; Janković RI; Lovcić P; Dzapo M
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():49-53. PubMed ID: 23120816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoietin-dependent anaemia: a possible complication of diabetic neuropathy.
    Hadjadj S; Torremocha F; Fanelli A; Brizard A; Bauwens M; Maréchaud R
    Diabetes Metab; 2001 Jun; 27(3):383-5. PubMed ID: 11431605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
    Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron supplementation in renal anemia.
    Fishbane S
    Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
    Holley JL; Nolan TA; Piraino B
    Clin Nephrol; 1992 Mar; 37(3):145-7. PubMed ID: 1563119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on the pathogenesis, pathology and treatment of the anemia of chronic renal failure.
    Brunier G
    J CANNT; 1990; ():15-7. PubMed ID: 2364042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaemia in older people with chronic heart failure: The potential cost.
    Man-Fai Sim V; Nam MC; Riley S; Yousef Z; Hurley J; Cheung WY; O'Mahony S
    Technol Health Care; 2009; 17(5-6):377-85. PubMed ID: 20051617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P; Andre JL; Treize G; Leroy B
    Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anemia in chronic renal insufficiency].
    Feiman R; Mena Castro E; Gordillo Paniagua G
    Bol Med Hosp Infant Mex; 1981; 38(2):231-41. PubMed ID: 7259844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of recombinant erythropoietin with patients on programmed hemodialysis].
    Rozental' RL; Zezina LIu; Spudass AV
    Ter Arkh; 1991; 63(12):110-3. PubMed ID: 1803587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anemia treatment with erythropoietin in pregnant renal recipients.
    Cyganek A; Pietrzak B; Kociszewska-Najman B; Sanko-Resmer J; Paczek L; Wielgos M
    Transplant Proc; 2011 Oct; 43(8):2970-2. PubMed ID: 21996203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

  • 35. [Requirement for blood in hemodialyzed patients with chronic renal failure in the period before and after introduction to erythropoietin (r-HuEPO) treatment].
    Wiecek A; Kokot F; Spiechowicz U; Cieplok J; Czerwieńska B; Strzelczyk P; Dyjas R
    Przegl Lek; 1996; 53(12):866-9. PubMed ID: 9163010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM; Mooij JM; Roujouleh H
    Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
    [No Abstract]   [Full Text] [Related]  

  • 37. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of erythropoietin treatment on tissue oxygenation in patients with severe transfusion dependent renal anaemia.
    Landgraf H; Grützmacher P; Garcia-Bartels C; Bergmann M; Ehrly AM; Schoeppe W
    Eur J Med; 1993; 2(7):393-7. PubMed ID: 8258026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human erythropoietin (rHuEPO) in the treatment of anaemia of chronic renal failure.
    Desai JD; Shah BV
    J Assoc Physicians India; 1991 Jun; 39(6):483-5. PubMed ID: 1938855
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cardio-renal syndrome and anaemia].
    Jakić M
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():38-45. PubMed ID: 20232550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.